Patents by Inventor Albert Paul Reed

Albert Paul Reed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant feline coronavirus S proteins
    Publication number: 20040063093
    Abstract: The present invention relates to polypeptides and proteins useful in the diagnosis and prevention of disease caused by feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV).
    Type: Application
    Filed: August 22, 2003
    Publication date: April 1, 2004
    Applicant: Pfizer, Inc.
    Inventors: Timothy J. Miller, Albert Paul Reed, Sharon R. Klepfer, Nancy E. Pfeiffer, Brian T. Suiter, Elaine V. Jones
  • Recombinant feline coronavirus S proteins
    Patent number: 6642359
    Abstract: The present invention relates to polypeptides and proteins useful in the diagnosis and prevention of disease caused by feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV).
    Type: Grant
    Filed: May 14, 2001
    Date of Patent: November 4, 2003
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Albert Paul Reed, Sharon R. Klepfer, Nancy E. Pfeiffer, Brian T. Suiter, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Patent number: 6602504
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Grant
    Filed: October 5, 2001
    Date of Patent: August 5, 2003
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Publication number: 20020127245
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Application
    Filed: October 5, 2001
    Publication date: September 12, 2002
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine Jones
  • Recombinant feline coronavirus S proteins
    Publication number: 20020115064
    Abstract: The present invention relates to polypeptides and proteins useful in the diagnosis and prevention of disease caused by feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV).
    Type: Application
    Filed: May 14, 2001
    Publication date: August 22, 2002
    Inventors: Timothy J. Miller, Albert Paul Reed, Sharon R. Klepfer, Nancy E. Pfeiffer, Brian T. Suiter, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Patent number: 6372224
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections.
    Type: Grant
    Filed: January 28, 2000
    Date of Patent: April 16, 2002
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed, Elaine V. Jones
  • Recombinant feline coronavirus S proteins
    Patent number: 6280974
    Abstract: The present invention provides polynucleotide molecules encoding portions of the S protein from feline infectious peritonitis virus (FIPV). The present invention further provides polynucleotide molecules encoding the entire S protein or portions thereof from feline enteric coronavirus (FECV). The polynucleotide molecules of the present invention are useful as diagnostic reagents.
    Type: Grant
    Filed: February 22, 1995
    Date of Patent: August 28, 2001
    Assignee: Pfizer Inc
    Inventors: Timothy J. Miller, Albert Paul Reed, Sharon R. Klepfer, Nancy E. Pfeiffer, Brian T. Suiter, Elaine V. Jones
  • Canine coronavirus S gene and uses therefor
    Patent number: 6057436
    Abstract: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene for prophylaxis, diagnostic, and treatment of CCV infections.
    Type: Grant
    Filed: November 23, 1994
    Date of Patent: May 2, 2000
    Assignee: Pfizer Inc.
    Inventors: Timothy J. Miller, Sharon Klepfer, Albert Paul Reed